Saturday , November 17 2018
Home / National-News / Strides partners with ICP-III Investment Advisors to fund its nascent Consumer Health Care business

Strides partners with ICP-III Investment Advisors to fund its nascent Consumer Health Care business

Bangalore, October , 2018 Strides Pharma Science Limited (Strides) today announced that its board of directors have approved the execution by Strides of definitive agreements with funds advised by ICP-III Investment Advisors (ICP) to provide growth capital and focused attention to its Consumer Healthcare Business (CHC). ICP would provide the business with a USD 20 Million capital for growth. The CHC business comprises of key brands including JointFlex®, Pediacare®, NiteThru™ and NixIt™ sold across key regulated and emerging markets. The business had Revenues of USD 6.4 Million for FY18.

The proposed transaction will be subject to customary closing conditions.

Key Terms

• The proposed transaction involves subscribing to the equity capital of Strides Consumer Pvt Ltd, India (SCPL) and Strides Global Consumer Healthcare Ltd, UK (SGCHL), which are currently wholly owned subsidiaries of the Company.
• The agreement also envisages SCPL to become a fully owned subsidiary of SGCHL, UK at a later date, subject to approval of Reserve Bank of India.

For Strides, MAPE Advisory Group acted as the transaction advisor.

About Strides CHC business

Strides CHC business currently operates key brands of JointFlex®, Pediacare®, NiteThru™ and NixIt™ in USA, India and other geographies globally, in Consumer Healthcare categories of smoking cessation, oral and topical analgesic, sleep aids and products for pediatric care.

About Admin

Check Also

Coffee Day Malnad Ultra 2018 flags off successfully in Chikmagalur

Bangalore, October  2018: The two day Coffee Day Malnad Ultra 2018 flagged off successfully from …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.